These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30831104)

  • 1. Bleeding and spotting with the levonorgestrel 13.5 mg intrauterine system: the impact of insertion timing.
    Shimoni N; Choudhury T; Goldman AR; Frondelli M; Chen PH
    Contraception; 2019 Jun; 99(6):340-344. PubMed ID: 30831104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
    Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
    Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen for the prevention of unscheduled bleeding in new users of the levonorgestrel 52-mg intrauterine system: a randomized controlled trial.
    Cohen MA; Simmons KB; Edelman AB; Jensen JT
    Contraception; 2019 Nov; 100(5):391-396. PubMed ID: 31226322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J; Lähteenmäki P
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of insertion of levonorgestrel-releasing intrauterine system: a randomised controlled trial.
    van der Heijden P; Geomini P; Herman MC; Veersema S; Bongers MY
    BJOG; 2017 Jan; 124(2):299-305. PubMed ID: 28012273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year after insertion: a systematic review and meta-analysis.
    Maldonado LY; Sergison JE; Gao X; Hubacher D
    Am J Obstet Gynecol; 2020 May; 222(5):451-468.e9. PubMed ID: 31589865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
    Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
    Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.
    Mejia M; McNicholas C; Madden T; Peipert JF
    Contraception; 2016 Nov; 94(5):556-560. PubMed ID: 27364099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
    Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
    Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use.
    Darney PD; Stuart GS; Thomas MA; Cwiak C; Olariu A; Creinin MD
    Contraception; 2018 Mar; 97(3):210-214. PubMed ID: 29038072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of embedment of the side arms of 52 mg levonorgestrel-intrauterine device on bleeding and pain: A prospective cohort study.
    van der Heijden PAHH; Bongers MY; Veersema S; Dieleman JP; Geomini PMAJ
    J Gynecol Obstet Hum Reprod; 2024 Jun; 53(6):102777. PubMed ID: 38531476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system.
    Lal S; Kriplani A; Kulshrestha V; Sharma M; Agarwal N
    Int J Gynaecol Obstet; 2010 May; 109(2):128-30. PubMed ID: 20223454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems.
    Frenz AK; Ahlers C; Beckert V; Gerlinger C; Friede T
    Eur J Contracept Reprod Health Care; 2021 Feb; 26(1):48-57. PubMed ID: 33269954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain and bleeding pattern related to levonorgestrel intrauterine system (LNG-IUS) insertion.
    Van Schoubroeck D; Van den Bosch T; Ameye L; Veldman J; Hindryckx A; Werbrouck E; Timmerman D
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):154-6. PubMed ID: 24029596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
    Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
    Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of levonorgestrel-releasing intrauterine system in early pregnancy: a case report].
    Gardyszewska A; Czajkowski K
    Ginekol Pol; 2012 Dec; 83(12):950-2. PubMed ID: 23488301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.